Here are the biggest voices on Wall Street Thursday: Citi begins acquisition of Gilead Sciences The company said it was bullish on the biotech’s HIV franchise. “We are starting coverage on Gilead with a Buy rating and a TP of $125.” Piper Sandler upgrades Campbell Soup from Neutral to Overweight. Piper sees an attractive entry point for the stock. He said he was thinking about it. “We upgraded CPB from Neutral to Overweight due to improved long-term growth expectations from Rao’s brands. U.S. measured retail sales and volume trends (formerly SOVO acquired brands) are improving; Even though the stock price has fallen about 15% since mid-September, we think this is a good buying opportunity. ” UBS begins acquisition of Cogent The company said it expects the internet services company’s earnings to accelerate significantly. “We initiate CCOI with a buy rating and a $102 PT. Oppenheimer reiterated NVDA as a buy and said the company is bullish for next week’s earnings.” Full-Stack AI Hardware In our view, NVDA is in the best position in the AI space due to its hardware/software capabilities. “We have repeatedly outperformed and raised our price target from $150 to $175.” Jefferies reiterated that Tesla is unchanged, and the company raised its price target from $195 to $300 per share. “Tesla… We should take advantage of the 30% revaluation of stock prices that exceeds $1 trillion.”Improve fairness in Trump’s election. “Assuming the market remains competitive, deregulation will raise the growth trajectory, but it will also raise investment requirements for Tesla and its competitors (AV, robots) in ventures with uncertain returns.” Bank of America has upgraded ArcelorMittal to neutral acquisition from Bank of America Steel company ArcelorMittal is a leader in every major global steel market, including automotive, construction, consumer electronics and packaging. Morgan Stanley upgraded Doximity from underweight to equal weight, with Morgan Stanley saying the consensus forecast was too low for an online networking service. “Doximity’s business is showing renewed momentum, and conservative fourth-quarter guidance suggests room for upward revisions to expectations,” medical experts said. Evercore ISI initiates negative tactical call on Target The company said it expects sales trends to slow heading into next week’s earnings call. “We have initiated a negative TAP call on TGT ahead of earnings on November 20th, with a downside potential of $140.” KeyBank changes Papa John’s stock from overweight to sector weight KeyBank said it expects the recovery in Papa John’s stock to slow. Industry conversations suggest that recovery in sales trends and store-level profitability metrics may take longer than previously anticipated and may require reinvestment on our part and on our part. We downgrade Papa John’s International shares from overweight to sector weight because of the Its franchisees. ” JPMorgan launches Blueprint Medicine with acquisition JPMorgan said the biotech company is an “underappreciated blockbuster franchise.” “We will begin covering Blueprint Medicines (BPMC) with an OW rating and a December 2025 PT of $126.” Compass Points Upgrades BXP to Buy from Neutral Country Compass says real estate investment trust is undervalued He said it was appreciated. “Despite having a better balance sheet and higher average quality office portfolio, this blue-chip office has lagged +30% year-to-date behind two other Manhattan-focused offices, leading to BXP Upgraded to Buy at $88 PT.As investment grade credit, BXP has continued access to the unsecured debt market.”Wells Fargo reiterates Burlington is a top choice. He said Burlington remains the frontrunner as the company closes its accounts later this month. “BURL could outperform Q3 (as exit traffic accelerates).” JPMorgan reiterates its overweight position on Netflix. He said it remains strong. “Investor sentiment regarding the content of the fourth quarter remains strong through the end of the year, with confidence in the NFLX conference, exceeding our 2025 revenue outlook of +11% to 13%, our 2025 operating margin target of 28%, and FCF Barclays upgrades American Airlines from underweight to equal weight Barclays said business travel has improved and it will renegotiate its card contracts with the airline. “We upgrade American Airlines to equal weight as balance sheet leverage weakens, business share has room for improvement, and airlines renegotiate co-branded card agreements in 2025.” Morgan Stanley Morgan Stanley reiterates that meta is overweight, saying meta is benefiting greatly from AI. “META’s scale and distribution has accelerated the adoption of Meta AI to levels comparable to ChatGPT and Gemini, even though it was only released in April 2024.” Needham reiterates the case for Amazon acquisition Needham raised his price target on the company’s stock from $210 to $250 per share after a series of channel checks. “ AMZN is focused on customer-centric innovation, and most of its product development comes directly from customer feedback. AMZN’s culture ensures that every FTE (full-time equivalent) pitches an idea and JP Morgan Adds Negative Factors to ResMed The company maintains its Overweight rating on ResMed, but the company maintains an Overweight rating for the sleep apnea company in the coming months. He said he was concerned about a series of negative factors. “First, following the results of the SURMOUNT-OSA trial, we are hopeful that the FDA will allow Eli Lilly’s Zepbound label extension to include patients with obstructive sleep apnea (OSA).Second. , Novo Nordisk plans to announce results from a Phase 3 trial of CagriSema, which resulted in more than 25% weight loss, which is a greater reduction than currently approved drugs,” Jeffries said. , reiterated its intention to acquire Microsoft. Jeffries said he has become even more bullish on the company’s stock following the visit to the company’s headquarters. “We believe that MSFT will be re-evaluated as it continues to execute.”
